Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001–2020)

L Huang, S Jiang, Y Shi - Journal of hematology & oncology, 2020 - Springer
Tyrosine kinases are implicated in tumorigenesis and progression, and have emerged as
major targets for drug discovery. Tyrosine kinase inhibitors (TKIs) inhibit corresponding …

Hyperinsulinaemia in cancer

EJ Gallagher, D LeRoith - Nature Reviews Cancer, 2020 - nature.com
Elevated circulating insulin levels are frequently observed in the setting of obesity and early
type 2 diabetes, as a result of insensitivity of metabolic tissues to the effects of insulin. Higher …

The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer

JL Hsu, MC Hung - Cancer and Metastasis Reviews, 2016 - Springer
Breast cancer affects approximately 1 in 8 women, and it is estimated that over 246,660
women in the USA will be diagnosed with breast cancer in 2016. Breast cancer mortality has …

A first-generation pediatric cancer dependency map

NV Dharia, G Kugener, LM Guenther, CF Malone… - Nature …, 2021 - nature.com
Exciting therapeutic targets are emerging from CRISPR-based screens of high mutational-
burden adult cancers. A key question, however, is whether functional genomic approaches …

Predictive validity in drug discovery: what it is, why it matters and how to improve it

JW Scannell, J Bosley, JA Hickman… - Nature Reviews Drug …, 2022 - nature.com
Successful drug discovery is like finding oases of safety and efficacy in chemical and
biological deserts. Screens in disease models, and other decision tools used in drug …

Therapeutic targeting of the IGF axis

E Osher, VM Macaulay - Cells, 2019 - mdpi.com
The insulin like growth factor (IGF) axis plays a fundamental role in normal growth and
development, and when deregulated makes an important contribution to disease. Here, we …

Type 2 diabetes mellitus and cancer: the role of pharmacotherapy

G Shlomai, B Neel, D LeRoith… - Journal of Clinical …, 2016 - ascopubs.org
Purpose Type 2 diabetes mellitus (T2DM) is becoming increasingly prevalent worldwide.
Epidemiologic data suggest that T2DM is associated with an increased incidence and …

Costs and causes of oncology drug attrition with the example of insulin-like growth factor-1 receptor inhibitors

V Jentzsch, L Osipenko, JW Scannell… - JAMA Network …, 2023 - jamanetwork.com
Importance The development of oncology drugs is expensive and beset by a high attrition
rate. Analysis of the costs and causes of translational failure may help to reduce attrition and …

Gemcitabine resistance of pancreatic cancer cells is mediated by IGF1R dependent upregulation of CD44 expression and isoform switching

C Chen, S Zhao, X Zhao, L Cao, A Karnad… - Cell Death & …, 2022 - nature.com
Chemoresistance in pancreatic cancer cells may be caused by the expansion of inherently
resistant cancer cells or by the adaptive plasticity of initially sensitive cancer cells. We …

IGF-IR signaling in epithelial to mesenchymal transition and targeting IGF-IR therapy: overview and new insights

H Li, IS Batth, X Qu, L Xu, N Song, R Wang, Y Liu - Molecular cancer, 2017 - Springer
The insulin-like growth factor-I (IGF-I) signaling induces epithelial to mesenchymal transition
(EMT) program and contributes to metastasis and drug resistance in several subtypes of …